Spears Abacus Advisors LLC Integra Lifesciences Holdings Corp Transaction History

Spears Abacus Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$23.14 - $34.72 $5.1 Million - $7.66 Million	220,588 Added 1087.28%	240,876 $7.02 Million
Q1 2024 May 10, 2024	BUY	$33.4 - $45.2 $677,619 - $917,017	20,288 New	20,288 $719,000
Q4 2021 Feb 14, 2022	SELL	$62.47 - $73.25 $298,918 - $350,501	-4,785 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$66.79 - $76.63 $77,409 - $88,814	1,159 Added 31.96%	4,785 $327,000
Q1 2021 May 14, 2021	SELL	$62.63 - $71.15 $15,908 - $18,072	-254 Reduced 6.55%	3,626 $251,000
Q4 2020 Feb 12, 2021	BUY	$43.31 - $66.55 $168,042 - $258,214	3,880 New	3,880 $252,000
Q3 2020 Nov 16, 2020	SELL	$43.33 - $51.72 $185,755 - $221,723	-4,287 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$41.42 - $55.57 $177,567 - $238,228	4,287 New	4,287 $201,000

241

75.3M

585K

21.3K

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

Get notified when there are updates to the investment portfolio of Spears Abacus Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Spears Abacus Advisors LLC with notifications on news.